about
Biomarkers of HIV-associated Cancer.Medical history, lifestyle, family history, and occupational risk factors for sporadic Burkitt lymphoma/leukemia: the Interlymph Non-Hodgkin Lymphoma Subtypes ProjectPrimary burkitt lymphoma of the fourth ventricle in an immunocompetent young patient.Treatment Outcomes of Rituximab Plus Hyper-CVAD in Korean Patients with Sporadic Burkitt or Burkitt-like Lymphoma: Results of a Multicenter Analysis.Aggressive B-cell lymphomas: how many categories do we need?Apoptosis resistance, mitotic catastrophe, and loss of ploidy control in Burkitt lymphoma.Towards curative therapy in burkitt lymphoma: the role of early african studies in demonstrating the value of combination therapy and CNS prophylaxis.The PCBP1 gene encoding poly(rC) binding protein I is recurrently mutated in Burkitt lymphoma.Autologous and allogeneic transplantation for burkitt lymphoma outcomes and changes in utilization: a report from the center for international blood and marrow transplant researchClinical significance of MYC expression and/or "high-grade" morphology in non-Burkitt, diffuse aggressive B-cell lymphomas: a SWOG S9704 correlative studyTreatment of adolescents with aggressive B-cell malignancies: the pediatric experience.Unusual case of metachronous EBV-associated B-cell and NK/T-cell lymphoma mimicking polymyositis-diagnostic challenges and pitfalls.Sequential karyotyping in Burkitt lymphoma reveals a linear clonal evolution with increase in karyotype complexity and a high frequency of recurrent secondary aberrations.Kinetics of hematogones in bone marrow samples from patients with non-Hodgkin lymphomas treated with rituximab-containing regimens: a flow cytometric study.Dose-intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status: final results of a phase 2 study (Burkimab).Complete Remission of Burkitt Lymphoma After Surgical Excision: A Case Report.Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimens.A unique bone marrow lymphoma patient presenting with an isolated mass: A case report.Impact of chemotherapy regimen and rituximab in adult Burkitt lymphoma: a retrospective population-based study from the Nordic Lymphoma Group.
P2860
Q33856851-C95ACA63-8284-4D6E-88CC-EFA7D1955F26Q34137897-AB972416-ACE5-451B-BFBD-2F0D144DE574Q34182340-F65E6839-23FC-4E1E-874D-6762F10914A4Q35429833-D241D389-48B0-45A6-B9CE-B6A84F3DFA45Q35527893-24822822-FA5B-4F97-A86D-7A3762715CC4Q35535592-5F849A6E-4797-4938-B2B8-5A048DB63DA6Q35687432-DFD9E570-B993-4F2A-B774-4B3248B14B8CQ35691157-833CED3E-4C50-49BA-BEAA-B2246A4A8061Q36557201-8332F7A6-A336-401F-8AC4-88ADB75A68A6Q37640313-0B6C523F-01E4-4225-AD84-E8E33EFF793FQ38118167-9310878D-2E7D-41B6-8BE7-1A08E7D5D87EQ38130474-AB5B9092-C745-4902-8FC9-0B08381CF72CQ38536238-28BE02FD-AA7D-47E5-8B48-A3197C578D22Q40962973-ECD77641-70A4-466C-AE56-5219CBCBD675Q42277126-A5CB3F87-AF18-4BB4-89F5-ED4611063423Q42526609-4986A5D0-D432-4C19-A359-48D6F97E3816Q47361098-C94AA591-1249-4D93-A37A-E0EE47BC00E0Q49475746-94E8065C-5BAD-4AFA-9B3F-79D7D7150116Q51828321-07893953-666C-42DC-91C7-6B62AA0DE77B
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Burkitt lymphoma in adults.
@en
Burkitt lymphoma in adults.
@nl
type
label
Burkitt lymphoma in adults.
@en
Burkitt lymphoma in adults.
@nl
prefLabel
Burkitt lymphoma in adults.
@en
Burkitt lymphoma in adults.
@nl
P2860
P1476
Burkitt lymphoma in adults.
@en
P2093
David C Linch
P2860
P304
P356
10.1111/J.1365-2141.2011.08877.X
P407
P577
2011-09-19T00:00:00Z